<DOC>
	<DOCNO>NCT00382304</DOCNO>
	<brief_summary>Approximately 24 patient enter study take place Canada . The aim study determine investigational drug absorb ( take ) patient C. difficile-associated diarrhea ( CDAD ) . The investigational drug give addition current standard antibiotic treatment patient receive active medication . All study relate care provide include doctor visit , physical exam , laboratory test , study medication . The total length participation approximately 7 day .</brief_summary>
	<brief_title>A Study Absorption GT267-004 Patients With Clostridium Difficile-Associated Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Enterocolitis , Pseudomembranous</mesh_term>
	<criteria>18 year age older The presence CDAD time enrollment likely etiology diarrhea &gt; 72 hour treatment metronidazole , vancomycin , antibacterial therapy specifically target current acute episode CDAD Patient consider sufficiently stable clinically complete study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Clostridium difficile-associated diarrhea</keyword>
	<keyword>C. difficile</keyword>
	<keyword>CDAD</keyword>
	<keyword>Clostridium difficile</keyword>
	<keyword>Clostridium difficile Disease</keyword>
	<keyword>Clostridium Enterocolitis</keyword>
	<keyword>Antibiotic-Associated Colitis</keyword>
	<keyword>Infectious diarrhea</keyword>
</DOC>